Table 1.
Patient backgrounds comparing warfarin and dabigatran groups
| Warfarin | Dabigatran | p value | |
|---|---|---|---|
| (n = 65) | (n = 65) | ||
| Age (years) | 67 ± 8 | 65 ± 10 | 0.113 |
| Men | 46 (71 %) | 44 (68 %) | 0.424 |
| Previous heart failure | 15 (23 %) | 12 (18 %) | 0.332 |
| Hypertension | 35 (54 %) | 40 (62 %) | 0.238 |
| Diabetes mellitus | 5 (8 %) | 9 (14 %) | 0.197 |
| Cerebral infarction | 7 (11 %) | 2 (3 %) | 0.083 |
| CHADS2 score | 1.2 ± 1.0 | 1.1 ± 0.9 | 0.465 |
| AF | |||
| Paroxysmal | 21 (32 %) | 35 (54 %) | 0.011 |
| Persistent | 44 (68 %) | 30 (46 %) | |
Italics indicate metastatic SNs
AF atrial fibrillation